| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |